Zaloguj Zarejestruj się zadarmo

Neuland Laboratories organizacji Przewidiwany EPS Q/Q

Jaka jest wartość Przewidiwany EPS Q/Q organizacji Neuland Laboratories?

Wartość Przewidiwany EPS Q/Q organizacji Neuland Laboratories Limited to 66.02%

Jaka jest definicja Przewidiwany EPS Q/Q?



Perspektywiczna kwartalna stopa wzrostu z roka (Estimated quarterly EPS growth rate) rok do roku, to szacowany wzrost wartości EPS spółki na następny kwartał w porównaniu do wyników z poprzedniego kwartału.

The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.

Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.

Przewidiwany EPS Q/Q firm w Health Care sektor na BSE w porównaniu do Neuland Laboratories

Czym się zajmuję organizacja Neuland Laboratories?

Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.

Firmy z przewidiwany eps q/q podobne do Neuland Laboratories